News and reporting on prostate cancer.
TD Cowen Initiates Coverage of MDxHealth With Outperform Rating
Analyst Dan Brennan wrote in a note to investors that the company's position in an under-penetrated market bodes well for future revenue growth.
Labcorp Licenses Proteomedix Prostate Cancer Test
Labcorp obtained exclusive US rights to the test, which is intended for assessing risk of clinically significant prostate cancer in men with elevated PSA.
Veracyte Q1 Revenues up 22 Percent as Firm Beats Analyst Estimates
The company's testing revenues rose 29 percent in Q1 thanks to increased adoption of its Decipher Prostate and Afirma tests.
Medicare Covering Epic Sciences ctDNA Breast Cancer Panel, MDxHealth's Select MDx Test
Medicare is covering the 56-gene ctDNA panel that forms one component of the DefineMBC multiomic liquid biopsy test.
Prominent players in the market cited maturing validity data and updated guidelines that have led to growing awareness among doctors and patients.
Mar 8, 2023
UK NHS Expands Access to Ibex Cancer Diagnostics
Oct 31, 2022
Oct 17, 2022
Immunovia, Proteomedix to Collaborate on R&D Efforts
Aug 23, 2022